ClinicalTrialsFinder

HPV 16+ Recurrent or Metastatic Cancer Clinical Trials in Shanghai

1 recruitingShanghai, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors

Cervical CancerHNSCCHPV 16+ Recurrent or Metastatic Cancer
Therorna12 enrolled1 locationNCT07081984